LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mitochondrial Peptide Protects Brain from Age-Related Dementias

By LabMedica International staff writers
Posted on 04 Oct 2018
Image: The humanin gene is found within the 16S rRNA gene (MT-RNR2) in the mitochondrial genome (Photo courtesy of Wikimedia Commons).
Image: The humanin gene is found within the 16S rRNA gene (MT-RNR2) in the mitochondrial genome (Photo courtesy of Wikimedia Commons).
A recent study contributed new evidence that strengthens the hypothesis that the peptide humanin protects the brain against the development of Alzheimer's disease and other age-related dementias.

Humanin (HN) is a 24-amino acid mitochondria-associated peptide. Since its initial discovery more than 10 years ago, a role for HN has been reported in many biological processes such as apoptosis, cell survival, substrate metabolism, inflammatory response, and response to stressors such as oxidative stress, ischemia, and starvation. Mounting evidence has suggested that HN and other mitochondrial derived peptides play a role in several age-related conditions including neurodegenerative disease.

In light of findings that HN levels decrease with age, investigators at the University of Southern California (Los Angeles, USA) sought to confirm that humanin played an important function in the aging process and the onset of age-related diseases.

To this end, they used a mitochondrial GWAS (genome-wide association study) to identify a specific single-nucleotide polymorphism (SNP) in the humanin-coding region of the mitochondrial genome that was associated with a 14% decrease in circulating humanin levels. In a large, independent cohort, consisting of a nationally representative sample of older adults, the investigators found that this SNP was associated with accelerated cognitive aging; supporting the concept that humanin is an important factor in cognitive aging.

The investigators further reported in the September 21, 2018, online edition of the journal Scientific Reports that mice injected with humanin experienced a delay in cognitive decline associated with aging.

"Because of the beneficial effects of humanin, a decrease in circulating levels could lead to an increase in several different diseases of aging, particularly in dementia," said senior author Dr. Pinchas Cohen, professor of gerontology, medicine, and biological sciences at the University of Southern California. "This provides the first evidence that a variation in the sequence of a mitochondrial peptide is associated with a change in the level of peptides and the first conclusive demonstration that mitochondrial peptides are encoded in and regulated through mitochondrial DNA."

Related Links:
University of Southern California

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Collection and Transport System
PurSafe Plus®

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more